What did @therestoreclinic actually say?
The creator addressed a viewer question about whether HCG is required during testosterone replacement therapy. Their answer covered three distinct claims: HCG is an optional add-on to TRT, not a requirement; HCG works by mimicking luteinizing hormone to stimulate intra-testicular testosterone production; and HCG does not raise FSH or LH levels. They also correctly identified that intra-testicular testosterone has a spillover effect on Sertoli cells, which supports sperm production. The terminology used, including ITT (intra-testicular testosterone) and the Leydig-Sertoli cell relationship, suggests some clinical familiarity with the subject. The core message is that HCG is a fertility-preserving optional add-on, not a mandatory component of TRT.
Does the science back this up?
Mostly, yes. The claim that HCG mimics LH is accurate and well-documented. HCG binds to the LH/CG receptor on Leydig cells, stimulating steroidogenesis and intra-testicular testosterone production. This is the mechanism behind its use in hypogonadal men who want to preserve testicular size and fertility during TRT. A 2005 study by Coviello et al. in the Journal of Clinical Endocrinology and Metabolism confirmed that low-dose HCG co-administered with testosterone maintained intra-testicular testosterone concentrations that would otherwise be suppressed by exogenous testosterone. On the FSH question, the creator is also correct. HCG does not directly stimulate FSH release. FSH is controlled by GnRH pulsatility and feedback from inhibin B from Sertoli cells. HCG has no direct effect on the pituitary's FSH secretion pathway. However, the mechanism connecting ITT spillover to Sertoli cell stimulation is slightly more nuanced than presented.
What did they get wrong (or right)?
They got the big picture right but fumbled one anatomical detail. The creator said HCG stimulates Sertoli cells via "spillover" of intra-testicular testosterone. That is partially accurate, but incomplete. Sertoli cells are actually stimulated primarily by FSH and by androgen receptor activation from ITT. The spillover mechanism is real, but calling it the way HCG "induces sperm production" simplifies a more complex FSH-dependent process. ITT alone cannot fully maintain spermatogenesis without FSH in most men. A 2013 review by Jarow and Lipshultz in Fertility and Sterility noted that FSH plays a co-regulatory role in spermatogenesis that ITT alone does not entirely replace. The creator also mislabeled "latic cells" when they clearly meant Leydig cells. That is a verbal slip, but in a health video with over 13,000 views, the terminology matters. Giving credit where it is due: correctly identifying HCG as elective rather than required is an important and often misunderstood point in TRT discussions.
What should you actually know?
If you are on TRT and concerned about fertility or testicular atrophy, HCG is a legitimate and commonly used option, but it is not automatically part of every TRT protocol. The evidence for HCG preserving intra-testicular testosterone is solid. The evidence that HCG alone is sufficient to maintain full spermatogenesis in all men is weaker. Some men need FSH supplementation (via FSH injections or clomiphene) in addition to HCG to achieve fertility goals. A 2009 study by Schopohl et al. in the European Journal of Endocrinology showed that men with hypogonadotropic hypogonadism often required combined HCG and FSH therapy to achieve adequate sperm counts. If fertility is your actual goal and not just testicular volume maintenance, talk to a reproductive endocrinologist, not just a TRT clinic. The distinction matters clinically.